Loading...

Nanosonics Limited

NNCSF•PNK
Healthcare
Medical - Instruments & Supplies
$2.80
$-0.01(-0.18%)
U.S. Market opens in 2h 17m

Nanosonics Limited (NNCSF) Stock Overview

Explore Nanosonics Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap849.5M
P/E Ratio58.07
EPS (TTM)$0.05
ROE0.10%
Fundamental Analysis

AI Price Forecasts

1 Month$2.49
3 Months$2.87
1 Year Target$3.11

NNCSF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Nanosonics Limited (NNCSF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 67.48, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $3.11.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 58.07 and a market capitalization of 849.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.18%
5-Day Change
-0.36%
1-Month Change
27.85%
3-Month Change
7.69%
6-Month Change
-2.78%
Year-to-Date (YTD) Change
-3.45%
1-Year Change
0.72%
3-Year Change
-13.85%
5-Year Change
-42.39%
All-Time (Max) Change
418.52%

Contact Information

https://www.nanosonics.com.au
61 2 8063 1600
Building A, Macquarie Park, NSW, 2113

Company Facts

4,660 Employees
IPO DateAug 13, 2012
CountryAU
Actively Trading

Frequently Asked Questions